Observations placeholder
Natrecor
Identifier
019675
Type of Spiritual Experience
Background
A description of the experience
Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldoesterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation.
Neseritide was believed initially to be beneficial for acute decompensated congestive heart failure.
Side effects
Common side effects include:
- Low blood pressure (11% of patients)
- Headache
- Nausea
- Slow heart rate
- Kidney failure
More rare side effects include:
- Confusion
- Paresthesia
- Somnolence
- Tremor
On Jan, 21, 2016: 490 people reported to have side effects when taking Natrecor. Among them, 1 people (0.20%) has Hallucination.
Time on Natrecor when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 21, 2016: 490 people reported to have side effects when taking Natrecor. Among them, 47 people (9.59%) have Death.
Time on Natrecor when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Natrecor :
Female | Male | |
Death | 53.85% | 46.15% |
Age of people who have Death when taking Natrecor :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 2.50% | 0.00% | 0.00% | 0.00% | 0.00% | 10.00% | 17.50% | 70.00% |
Top conditions involved for these people :
- Hypertension (6 people, 12.77%)
- Decreased ventricular afterload (5 people, 10.64%)
- Fluid overload (4 people, 8.51%)
- Heart transplant (4 people, 8.51%)
- Sepsis (4 people, 8.51%)